These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 10525381)
41. [Prediction of malignant transformation of hydatidiform mole by mRNA determination of matrix metalloproteinases and tissue inhibitor of metalloproteinases]. Li Z; Xiang Y; Dai L Zhonghua Fu Chan Ke Za Zhi; 2000 Sep; 35(9):547-50. PubMed ID: 11775947 [TBL] [Abstract][Full Text] [Related]
42. Apoptosis in gestational trophoblastic disease is correlated with clinical outcome and Bcl-2 expression but not Bax expression. Wong SY; Ngan HY; Chan CC; Cheung AN Mod Pathol; 1999 Nov; 12(11):1025-33. PubMed ID: 10574599 [TBL] [Abstract][Full Text] [Related]
43. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance. Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148 [TBL] [Abstract][Full Text] [Related]
44. Expression of merosin, a tissue-specific basement membrane protein, in the intermediate trophoblast cells of choriocarcinoma and placenta. Leivo I; Laurila P; Wahlström T; Engvall E Lab Invest; 1989 Jun; 60(6):783-90. PubMed ID: 2471877 [TBL] [Abstract][Full Text] [Related]
45. Expression of cyclin E in placentas with hydropic change and gestational trophoblastic diseases: implications for the malignant transformation of trophoblasts. Kim YT; Cho NH; Ko JH; Yang WI; Kim JW; Choi EK; Lee SH Cancer; 2000 Aug; 89(3):673-9. PubMed ID: 10931468 [TBL] [Abstract][Full Text] [Related]
47. [Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix]. Zhou CY; Yao JF; Chen XD Ai Zheng; 2002 Jul; 21(7):735-9. PubMed ID: 12479097 [TBL] [Abstract][Full Text] [Related]
48. Endothelial nitric oxide synthase expression in gestational trophoblastic diseases. Barut A; Harma M; Arikan I; Harma MI; Barut F Int J Gynecol Cancer; 2010 Apr; 20(3):337-40. PubMed ID: 20375793 [TBL] [Abstract][Full Text] [Related]
49. [Expression of matrix metalloproteinases and their inhibitors in fetal skin and their biological significance]. Li WJ; Chen W; Fu XB; Zhu RZ Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 May; 18(5):303-6. PubMed ID: 16701000 [TBL] [Abstract][Full Text] [Related]
50. Developmental regulation of tissue transglutaminase during human placentation and expression in neoplastic trophoblast. Hager H; Gliemann J; Hamilton-Dutoit S; Ebbesen P; Koppelhus U; Jensen PH J Pathol; 1997 Jan; 181(1):106-10. PubMed ID: 9072011 [TBL] [Abstract][Full Text] [Related]
51. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior]. He DS; Chen MZ; Wang HJ; Ke CL; Yan C; Zheng H; Hong YS Ai Zheng; 2002 Oct; 21(10):1124-8. PubMed ID: 12508658 [TBL] [Abstract][Full Text] [Related]
52. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis. Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384 [TBL] [Abstract][Full Text] [Related]
53. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats]. Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283 [TBL] [Abstract][Full Text] [Related]
54. New concepts in trophoblastic growth and differentiation with practical application for the diagnosis of gestational trophoblastic disease. Shih IM; Kurman RJ Verh Dtsch Ges Pathol; 1997; 81():266-72. PubMed ID: 9474880 [TBL] [Abstract][Full Text] [Related]
55. Matrix metalloproteinases (MMP-2 and MMP-9) and tissue inhibitor-2 of matrix metalloproteinases (TIMP-2) in the placenta and interplacental uterine wall in normal cows and in cattle with retention of fetal membranes. Walter I; Boos A Placenta; 2001 May; 22(5):473-83. PubMed ID: 11373158 [TBL] [Abstract][Full Text] [Related]
56. Immunohistochemical expression of matrix metalloproteinases 1 and 2 (MMP-1 and MMP-2) and tissue inhibitor of metalloproteinase 2 (TIMP-2) in ruptured and non-ruptured tubal ectopic pregnancies. Kucera E; Tangl S; Klem I; König F; Grossschmidt K; Kainz C; Sliutz G Wien Klin Wochenschr; 2000 Sep; 112(17):749-53. PubMed ID: 11042903 [TBL] [Abstract][Full Text] [Related]
57. Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole. Medeiros F; Callahan MJ; Elvin JA; Dorfman DM; Berkowitz RS; Quade BJ Int J Gynecol Pathol; 2008 Apr; 27(2):247-51. PubMed ID: 18317216 [TBL] [Abstract][Full Text] [Related]
58. Low molecular mass polypeptide-2 in human trophoblast: over-expression in hydatidiform moles and possible role in trophoblast cell invasion. Fu JJ; Lin P; Lv XY; Yan XJ; Wang HX; Zhu C; Tsang BK; Yu XG; Wang H Placenta; 2009 Apr; 30(4):305-12. PubMed ID: 19217658 [TBL] [Abstract][Full Text] [Related]
59. Expression of the Thomsen-Friedenreich antigen and of its putative carrier protein mucin 1 in the human placenta and in trophoblast cells in vitro. Jeschke U; Richter DU; Hammer A; Briese V; Friese K; Karsten U Histochem Cell Biol; 2002 Mar; 117(3):219-26. PubMed ID: 11914919 [TBL] [Abstract][Full Text] [Related]
60. Low-molecular weight heparin induces in vitro trophoblast invasiveness: role of matrix metalloproteinases and tissue inhibitors. Di Simone N; Di Nicuolo F; Sanguinetti M; Ferrazzani S; D'Alessio MC; Castellani R; Bompiani A; Caruso A Placenta; 2007 Apr; 28(4):298-304. PubMed ID: 16750851 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]